A comprehensive review on in vitro therapies for virus elimination and novel methods for virus protection in key horticultural crops [0.03%]
果蔬作物中病毒清除的体外培养技术及病毒防护新技术研究进展
Karuppasamy Thanuja,Rajangam Arulmozhiyan,Marimuthu Somasundaram Saraswathi et al.
Karuppasamy Thanuja et al.
This review examines the impact of viable in vitro methods and novel strategies on virus elimination in key horticultural crops. Virus diseases are a major threat to economically important horticultural crops, leading to severe financial lo...
Italian screening protocol and genotypes characterization for HCV elimination (2022-2023) in Ferrara's province: a real-world study [0.03%]
意大利费拉拉省2022-2023年HCV消除的筛查方案和基因型特征的实际情况研究
Nicolò Landini,Chiara Chiericati,Michela Boni et al.
Nicolò Landini et al.
Hepatitis C virus (HCV) is a worldwide health hazard, and in chronic form (nowadays affecting 50 million people - World Health Organization data) can be lethal. To forestall it, preventive screening is a mandatory approach. Since 2021, Ital...
Assessing pricing and affordability of HBV treatment in Asia-Pacific region: a barrier to elimination [0.03%]
亚太地区乙型肝炎治疗的定价和支付能力评估：消除乙肝的障碍
Jing Chen,Jidong Jia,Hui Zhuang et al.
Jing Chen et al.
Background: The Asia-Pacific (AP) region carries a substantial burden of HBV. Affordable HBV treatment is crucial to attain WHO's elimination goal. This study assesses the pricing and affordability of HBV treatment in AP....
Comments on "Recompensation of Chronic Hepatitis C-Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination Program" [0.03%]
针对“直接抗病毒治疗后慢性丙型肝炎相关失代偿期肝硬化的再补偿：来自丙型肝炎病毒消除项目的一项前瞻性队列研究”的评论
Niteen Kumar,Abhideep Chaudhary
Niteen Kumar
Hepatitis B core-related antigen as a promising serological marker for monitoring hepatitis B virus cure [0.03%]
乙型肝炎核心相关抗原有望成为监测乙型肝炎病毒消除的血清学标志物
Yue Qiu,Qiao Tang,Xiao-Qing Liu et al.
Yue Qiu et al.
Hepatitis B virus (HBV) infection is a global health concern. The current sequential endpoints for the treatment of HBV infection include viral suppression, hepatitis B e antigen (HBeAg) seroconversion, functional cure, and covalently close...
Apichat Kaewdech,Phunchai Charatcharoenwitthaya,Teerha Piratvisuth
Apichat Kaewdech
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections remain significant public health challenges in Asia, affecting millions and contributing to substantial morbidity and mortality. The prevalence of these infections varies across...
Economic evaluation of mass screening as a strategy for hepatitis C virus elimination in South Korea [0.03%]
韩国大规模筛查作为消除丙型肝炎病毒战略的经济评估
Hwa Young Choi,Kyung-Ah Kim,Bo Young Park et al.
Hwa Young Choi et al.
Background: This study examines Hepatitis C virus (HCV) screening scenarios to meet World Health Organization (WHO) elimination targets (incidence ≤5 per 100,000, mortality ≤2 per 100,000) and assesses their timeframes ...
Control and Elimination of Hepatitis C Virus Among People With HIV in Australia: Extended Follow-up of the CEASE Cohort (2014-2023) [0.03%]
澳大利亚HIV患者中的丙型肝炎病毒控制和消除：CEASE队列（2014-2023）的延长随访研究
Marianne Martinello,Joanne M Carson,Jeffrey J Post et al.
Marianne Martinello et al.
Background: Approximately 10% of people with HIV in Australia had active hepatitis C virus (HCV) infection prior to availability of government-subsidized direct-acting antiviral (DAA) therapy in 2016. This analysis evalua...
Nanobiotechnology for efficient plum pox virus elimination from apricot plants [0.03%]
纳米生物技术在高效去除杏树桃缩叶病毒中的应用
C Pérez-Caselles,N Alburquerque,M Martín-Valmaseda et al.
C Pérez-Caselles et al.
Metallic nanoparticles have antimicrobial, virucidal, and anticancer activities and have been widely applied in medicine. In plants, silver nanoparticles have been used as preventive treatments in the greenhouse to reduce viral titers and s...
Cost-effectiveness and return on investment of hepatitis C virus elimination in China: A modelling study [0.03%]
在中国实现丙型肝炎病毒消除的成本效益和投资回报：基于模型的研究
Meiyu Wu,Jing Ma,Xuehong Wang et al.
Meiyu Wu et al.
Background: The WHO set the goal of eliminating hepatitis C virus (HCV) by 2030, with 80% and 65% reductions in HCV incidence and mortality rates, respectively. We aimed to evaluate the health benefits, cost-effectiveness...
耗时 0.16956 秒，为您在
48206918
条记录里面共找到 262 篇文章 [XML]